Abstract
Antibodies against the insulin-like growth factor-I (IGF-I) or the IGF-I receptor (IGF-IR) directly initiate a rapid (within 6 h) hypertrophy of isolated adult rat ventricular cardiomyocytes cultured in the absence of serum. Further, cardiomyocytes treated with either of these agonistic antibodies upregulate the expression of their genes for insulin-like growth factor-II (IGF-II) and the IGF-II receptor (IGF-IIR). Genistein, an inhibitor of the tyrosine kinase IGF-IR, also induces the cardiomyocytes to hypertrophy. Anti-IGF-II antibody inhibits the cardiomyocyte hypertrophy induced by anti-IGF-I and anti-IGF-IR antibodies or by genistein. Results are consistent with a model in which local production of IGF-II is upregulated when the IGF-IR signaling pathway is blocked and in which an IGF-II-mediated pathway, likely involving the IGF-IIR, then stimulates hypertrophy of the cardiomyocytes.
Similar content being viewed by others
References
Bang P, Hall K: Insulin-like growth factors as endocrine and paracrine hormones. In: P.N. Schofield (ed). The Insulin-like Growth Factors: Structure and Biological Functions. Oxford University Press, Oxford, 1992, pp 151–177
Jennische E, Isgaard J, Isaksson OGP: Local expression of insulin-like growth factors during tissue growth and regeneration. In: P.N. Schofield (ed). The Insulin-like Growth Factors: Structure and Biological Functions. Oxford University Press, Oxford, 1992, pp 221–239
Butler AA, LeRoith D: Control of growth by the somatotropic axis: Growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63: 141–164, 2001
Huang C-Y, Hao L-Y, Buetow DE: Insulin-like growth factor induced hypertrophy of cultured adult rat ventricular cardiomyocytes is L-type calcium-channel dependent. Mol Cell Biochem 2002 (in press)
Le Roith D, Werner H, Beitner-Johnson D, Roberts CT: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143–163, 1995
Steele-Perkins G, Turner J, Edman JC, Hari J, Pierce SC, Stover C, Rutter WJ, Roth RA: Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem 263: 11486–11492, 1988
Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F: Interactions of cathepsin D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 4: 1327–1335, 1990
De Leon DD, Wilson DM, Powers M, Rosenfeld RG: Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors 6: 327–336, 1992
Xiong L, Kasuya J, Li S-L, Kato J, Fujita-Yamaguchi Y: Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor. Proc Natl Acad Sci USA 89: 5356–5360, 1992
Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-I, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592–5596, 1987
Lavendero S, Foncea R, Pérez V, Sapag-Hagar M: Effect of inhibitors of signal transduction of IGF-I-induced protein synthesis associated with hypertrophy in cultured neonatal rat ventricular myocytes. FEBS Lett 422: 193–196, 1998
Haddad J, Decker ML, Hsieh LC, Lesch M, Samarel AM, Decker RS: Attachment and maintenance of adult cardiac myocytes in primary cell culture. Am J Physiol 255: C19–C27, 1988
Reiss K, Kajstura J, Zhang X, Li P, Szoke E, Olivetti G, Anversa P: Acute myocardial infarction leads to upregulation of the IGF-I autocrine system, DNA replication, and nuclear mitotic division in the remaining viable cardiac myocytes. Exp Cell Res 213: 463–472, 1994
Moxham C, Jacobs S: Insulin-like growth factor receptors. In: P.N. Schofield (ed). The Insulin-like Growth Factors: Structure and Biological Functions. Oxford University Press, Oxford, 1992, pp 80–109
Murphy LJ, Bell GI, Friesen HJ: Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 120: 1279–1282, 1987
Park GH, Buetow DE: Genes for insulin-like growth factors I and II are expressed in senescent rat tissues. Gerontology 37: 310–316, 1991
Brindle NPJ, Tavare JM, Dickens M, Whittaker J, Siddle K: Anti-(insulin receptor) monoclonal antibody-stimulated tyrosine phosphorylation in cells transfected with human insulin receptor cDNA. Biochem J 268: 615–620, 1990
Steele-Perkins G, Roth RA: Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells. J Biol Chem 265: 458–463, 1990
Lembo G, Hunter JJ, Chien KR: Signaling pathways for cardiac growth and hypertrophy: Recent advances and prospects for growth factor therapy. Ann NY Acad Sci 752: 115–127, 1995
Kornfeld S: Structure and function of the mannose-6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61: 307–330, 1992
Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL: Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8: 2953–2963, 1994
Jain S, Golde DW, Bailey R, Geffner ME: Insulin-like growth factor-I resistance. Endocr Rev 19: 625–646, 1998
Tappy L, Fujita-Yamaguchi Y, Lebon TR, Boden G: Antibodies to insulin-like growth factor I receptors in diabetes and other disorders. Diabetes 37: 1708–1714, 1988
Rights and permissions
About this article
Cite this article
Huang, CY., Hao, LY. & Buetow, D.E. Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF-I receptor is IGF-II-dependent. Mol Cell Biochem 233, 65–72 (2002). https://doi.org/10.1023/A:1015514324328
Issue Date:
DOI: https://doi.org/10.1023/A:1015514324328